Pedro Viveiros, MD

Articles by Pedro Viveiros, MD

A Pilot Trial of N-803 in Sarcoma: © Tariq - stock.adobe.com

A Pilot Trial of N-803: Patients With Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy

ByDaphne P. Edgren, BFA,Pedro Viveiros, MD,Seth M. Pollack, MD

October 28th 2026

A pilot early phase 1 trial (NCT07261657) represents the first clinical effort to activate persisting transferred rare persisting cells by using IL-15 superagonist N-803.

Pedro Viveiros, MD

Articles by Pedro Viveiros, MD

A Pilot Trial of N-803: Patients With Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy

Latest Updated Articles

Trending on CancerNetwork

Cardiac Assessment With Atrial Fibrillation and Closing Thoughts

FDA Receives BLA for Etentamig in Relapsed/Refractory Multiple Myeloma

Prior ICI Exposure Linked to Higher Dermatitis Risk With Lirafugratinib in FGFR2-Altered Tumors

Cisplatin-Free Pembrolizumab Regimen Misses Primary End Point in SMART-KEY

Encorafenib/Binimetinib Plus Pembrolizumab Extends PFS in BRAF V600 Melanoma